05/08/08, Research & Development Bayer and Regeneron start additional Phase 3 Study for VEGF Trap-Eye in Wet Age-related Macular Degeneration International study to evaluate efficacy and safety in treating a leading cause of blindness External Link: more
05/06/08, Research & Development Bayer Schering Pharma to market new low-dose oral contraceptive YAZ® in Europe Berlin, May 6, 2008 – Bayer Schering Pharma’s new low-dose oral contraceptive YAZ® has been approved in the EU.YAZ® will be the first oral contraceptive on the European market containin... External Link: more